Status:
NOT_YET_RECRUITING
Dietary Protein Sources and Glycemic Variability
Lead Sponsor:
Guangdong Provincial People's Hospital
Conditions:
Metabolic Disease
Diabetes
Eligibility:
All Genders
20-65 years
Phase:
NA
Brief Summary
This goal of trial is to evaluate the effects of plant-based vs. animal-based diets on glycemic variability in overweight or obese adults through a 3-week dietary intervention. The main question it a...
Detailed Description
Diabetes stands as one of the most rapidly escalating health challenges of the 21st century. Type 2 diabetes, which represents over 90% of all diagnosed cases, is the predominant form of the disease, ...
Eligibility Criteria
Inclusion
- Men or women aged 20-65 years.
- Body Mass Index (BMI) greater than 25kg/m2.
- Capable of using a smartphone application daily for taking photos and recording dietary intake.
- Maintained stable body weight over the past three months with a regular routine.
- Possess self-care ability for independent living.
- Not currently participating in any other clinical research projects.
- Signed the informed consent form and willing to adhere to and complete the entire research process.
Exclusion
- With diagnosed diabetes.
- With severe cardiovascular or cerebrovascular diseases (e.g., angina, myocardial infarction, or stroke) or cancer.
- Taking medications affecting weight or energy intake/energy expenditure in the last 3 months, including weight loss medications, antipsychotic drugs or other medications as determined by the study physician.
- Participating in weight loss treatments.
- History of severe gastrointestinal diseases or gastrointestinal surgery within the past 12 months.
- Those with allergic reactions to common foods (for example, eggs, nuts, grains) or those who are lactose intolerant.
- Women who are pregnant or plan to become pregnant.
- Diagnosis of HIV, hepatitis B or C, or active tuberculosis.
- Special groups who are specifically unsuitable for a diet consisting of whole plant proteins.
- Patients who are unwilling or unable to give informed consent.
Key Trial Info
Start Date :
August 1 2024
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2025
Estimated Enrollment :
96 Patients enrolled
Trial Details
Trial ID
NCT06525441
Start Date
August 1 2024
End Date
February 1 2025
Last Update
July 31 2024
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.